273 research outputs found
A performance comparison of the contiguous allocation strategies in 3D mesh connected multicomputers
The performance of contiguous allocation strategies can be significantly affected by the distribution of job execution times. In this paper, the performance of the existing contiguous allocation strategies for 3D mesh multicomputers is re-visited in the context of heavy-tailed distributions (e.g., a Bounded Pareto distribution). The strategies are evaluated and compared using simulation experiments for both First-Come-First-Served (FCFS) and Shortest-Service-Demand (SSD) scheduling strategies under a variety of system loads and system sizes. The results show that the performance of the allocation strategies degrades considerably when job execution times follow a heavy-tailed distribution. Moreover, SSD copes much better than FCFS scheduling strategy in the presence of heavy-tailed job execution times. The results also show that the strategies that depend on a list of allocated sub-meshes for both allocation and deallocation have lower allocation overhead and deliver good system performance in terms of average turnaround time and mean system utilization
An Evolutionary Reduction Principle for Mutation Rates at Multiple Loci
A model of mutation rate evolution for multiple loci under arbitrary
selection is analyzed. Results are obtained using techniques from Karlin (1982)
that overcome the weak selection constraints needed for tractability in prior
studies of multilocus event models. A multivariate form of the reduction
principle is found: reduction results at individual loci combine topologically
to produce a surface of mutation rate alterations that are neutral for a new
modifier allele. New mutation rates survive if and only if they fall below this
surface - a generalization of the hyperplane found by Zhivotovsky et al. (1994)
for a multilocus recombination modifier. Increases in mutation rates at some
loci may evolve if compensated for by decreases at other loci. The strength of
selection on the modifier scales in proportion to the number of germline cell
divisions, and increases with the number of loci affected. Loci that do not
make a difference to marginal fitnesses at equilibrium are not subject to the
reduction principle, and under fine tuning of mutation rates would be expected
to have higher mutation rates than loci in mutation-selection balance. Other
results include the nonexistence of 'viability analogous, Hardy-Weinberg'
modifier polymorphisms under multiplicative mutation, and the sufficiency of
average transmission rates to encapsulate the effect of modifier polymorphisms
on the transmission of loci under selection. A conjecture is offered regarding
situations, like recombination in the presence of mutation, that exhibit
departures from the reduction principle. Constraints for tractability are:
tight linkage of all loci, initial fixation at the modifier locus, and mutation
distributions comprising transition probabilities of reversible Markov chains.Comment: v3: Final corrections. v2: Revised title, reworked and expanded
introductory and discussion sections, added corollaries, new results on
modifier polymorphisms, minor corrections. 49 pages, 64 reference
Middle east respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, june to September 2013
Between June and September 2013, sera from 11 dromedary camels, 150 goats, 126 sheep and 91 cows were collected in Jordan, wher
Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats
<p>Abstract</p> <p>Background</p> <p>The present study investigated the effects of venlafaxine, an antidepressant drug with immunoregulatory properties on the inflammatory response and bone loss associated with experimental periodontal disease (EPD).</p> <p>Materials and Methods</p> <p>Wistar rats were subjected to a ligature placement around the second upper left molar. The treated groups received orally venlafaxine (10 or 50 mg/kg) one hour before the experimental periodontal disease induction and daily for 10 days. Vehicle-treated experimental periodontal disease and a sham-operated (SO) controls were included. Bone loss was analyzed morphometrically and histopathological analysis was based on cell influx, alveolar bone, and cementum integrity. Lipid peroxidation quantification and immunohistochemistry to TNF-α and iNOS were performed.</p> <p>Results</p> <p>Experimental periodontal disease rats showed an intense bone loss compared to SO ones (SO = 1.61 ± 1.36; EPD = 4.47 ± 1.98 mm, p < 0.001) and evidenced increased cellular infiltration and immunoreactivity for TNF-α and iNOS. Venlafaxine treatment while at low dose (10 mg/kg) afforded no significant protection against bone loss (3.25 ± 1.26 mm), a high dose (50 mg/kg) caused significantly enhanced bone loss (6.81 ± 3.31 mm, p < 0.05). Venlafaxine effectively decreased the lipid peroxidation but showed no significant change in TNF-α or iNOS immunoreactivity.</p> <p>Conclusion</p> <p>The increased bone loss associated with high dose venlafaxine may possibly be a result of synaptic inhibition of serotonin uptake.</p
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study
Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world.
Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231.
Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001).
Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication
Secondary prevention following coronary artery bypass surgery: a pilot study for improved patient education
This is an Open Access article distributed under the terms of the Open Access Policy
Assessing the Impact of the COVID-19 Pandemic on Tourism Workers’ Health and Well-being in Jordan
The current study assesses the impacts of the coronavirus (COVID-19) pandemic on tourism workers in Jordan between mid-March 2020 and June 2021 by investigating corona threats, financial impacts, resources impacts, social isolation, depression and personal control experienced by tourism workers during the COVID-19 pandemic, and how the threats of corona, financial impacts, resources impacts, social isolation, depression and personal control affect workers’ personal health and well-being. A quantitative survey method was applied by using a questionnaire. Data were collected from a sample of 400 workers from the tourism sector in Jordan. The study’s hypotheses were tested by using the Smart Partial Least Square (PLS) 3.3.3 Statistical Software. The findings of the study revealed that tourism workers are financially strained, socially isolated, psychologically depressed, uncontrolled their self, and have limited resources as a result of their dread of the pandemic and its negative impacts. It was also found that a significant negative direct effect of perceived coronavirus threats, financial impacts, resources impacts, and social isolation on workers’ depression and personal control, which in turn had a significant influence on workers’ personal health and well-being. In addition, this study proposed a model of the influence of coronavirus threats and its impacts on workers’ personal health and well-being, whereby workers’ depression and personal control fully mediate these relationships. The current study offers additional insights on the COVID-19 pandemic impacts on tourism workers’ personal health and well-being
Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990-2019: A Systematic Analysis From the Global Burden of Disease Study 2019
Background
Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. Methods
We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global Burden of Diseases, Injuries, and Risk Factors Study. We modelled multiple smoking-related indicators from 3625 nationally representative surveys. We completed systematic reviews and did Bayesian meta-regressions for 36 causally linked health outcomes to estimate non-linear dose-response risk curves for current and former smokers. We used a direct estimation approach to estimate attributable burden, providing more comprehensive estimates of the health effects of smoking than previously available. Findings
Globally in 2019, 1·14 billion (95% uncertainty interval 1·13–1·16) individuals were current smokers, who consumed 7·41 trillion (7·11–7·74) cigarette-equivalents of tobacco in 2019. Although prevalence of smoking had decreased significantly since 1990 among both males (27·5% [26·5–28·5] reduction) and females (37·7% [35·4–39·9] reduction) aged 15 years and older, population growth has led to a significant increase in the total number of smokers from 0·99 billion (0·98–1·00) in 1990. Globally in 2019, smoking tobacco use accounted for 7·69 million (7·16–8·20) deaths and 200 million (185–214) disability-adjusted life-years, and was the leading risk factor for death among males (20·2% [19·3–21·1] of male deaths). 6·68 million [86·9%] of 7·69 million deaths attributable to smoking tobacco use were among current smokers. Interpretation
In the absence of intervention, the annual toll of 7·69 million deaths and 200 million disability-adjusted life-years attributable to smoking will increase over the coming decades. Substantial progress in reducing the prevalence of smoking tobacco use has been observed in countries from all regions and at all stages of development, but a large implementation gap remains for tobacco control. Countries have a clear and urgent opportunity to pass strong, evidence-based policies to accelerate reductions in the prevalence of smoking and reap massive health benefits for their citizens
K-Shell Photoionization of the Oxygen Isonuclear Sequence
K-shell photoionization cross-section measurements for the oxygen isonuclear sequence from N-like to Li-like made at the SOLEIL Light Source are compared with SUNC, MCDF and R-matrix calculations
- …
